Parker Neuroscience offers IV and IM ketamine treatment modalities, Spravato (esketamine), and related psychiatric care for adults with treatment-resistant depression, PTSD, and anxiety — delivered with clinical precision, evidence-based protocols, and an uncompromising commitment to your safety.
"This is not a volume-based infusion clinic. This is a medical psychiatric service line built on defined protocols, real monitoring standards, and zero tolerance for unsafe delegation."
With over two decades in emergency medicine and a specialty focus in interventional psychiatry, Dr. Parker brings deep expertise across the full clinical spectrum — from acute crisis care to long-term mood disorder management. Parker Neuroscience was built on a foundation of regulatory precision and genuine patient-centered care.
Unlike high-volume ketamine clinics, Parker Neuroscience operates as a true medical psychiatric service — with individualized protocols, continuous monitoring, and a private clinical environment designed to support the therapeutic process.
Every service is delivered under direct APRN supervision with individualized protocols, careful monitoring, and a commitment to improving access to advanced treatment options.
IV and IM ketamine treatment options delivered through individualized protocols, continuous monitoring, and advanced safety equipment. Treatment planning is calibrated to clinical appropriateness, response, and access.
REMS-certified intranasal esketamine in a controlled clinical environment. Direct RN/APRN monitoring throughout every session, with strict, protocol-driven discharge criteria.
Primary care medication support related to mental health needs, with medication review, diagnostic clarity, and polypharmacy reduction when appropriate. Formal psychiatric medication management is anticipated in early 2027.
Structured coordination with your therapists, primary care providers, and psychiatric team. Secure health information exchange and shared EMR integration when available.
Parker Neuroscience is actively evaluating TMS and psychedelic-assisted therapy as federal and Nebraska regulatory standards evolve. Functional psychiatry add-ons also under development.
Candidacy for interventional treatment begins with a thorough evaluation with Dr. Parker to determine the safest, most effective path for you.
Schedule a ConsultationAt Parker Neuroscience, every decision is grounded in evidence, every protocol is defined, and every patient receives the direct care of a doctoral-prepared clinician — not delegated care, not group infusions, not shortcuts.
“As a therapist offering ketamine-assisted psychotherapy, I have great confidence in Dr Lisa Parker’s clinical judgment and medical expertise. Her commitment to safety aligns perfectly with my values at Soul Yoga Counseling. I truly appreciate having Parker Neuroscience as a trusted partner in our shared mission to support patient care.”
Melisa Perry, LCPC, LPC, NMIT
We serve adults who have experienced traditional psychiatric treatment without adequate relief, along with those who are exploring evidence-based alternatives to chronic medication management.
We actively collaborate with psychiatrists, therapists, and primary care providers. If you are a referring clinician, we welcome the opportunity to discuss your patient's care plan and coordinate treatment.
Evidence-based commentary on interventional psychiatry, ketamine therapy, and emerging treatments from Dr. Lisa Parker, DNP, APRN, NP.
Medically reviewed by Dr. Lisa Parker, DNP, APRN, NP | Owner & Clinical Director, Parker Neuroscience, Omaha, Nebraska Here’s the honest answer up front: ketamine is a promising, but still emerging, option for obsessive-compulsive disorder that hasn’t responded to standard treatment. Early research shows it can reduce obsessive thoughts quickly for some people, but the […]
If you’re partway through Spravato or IV ketamine treatment and need to change clinics, whether your clinic is closing, you’ve moved, your insurance changed, or it simply isn’t the right fit anymore, the most important thing to know is this: transferring care is a normal, manageable process, and your progress doesn’t disappear when your provider […]
Medically reviewed by Dr. Lisa Parker, DNP, APRN, NP — Owner & Clinical Director, Parker Neuroscience, Omaha, Nebraska Millions of people fill a prescription, take it exactly as directed, and keep waiting to feel like themselves again. For a large share of them, that feeling doesn’t come, or it arrives as a kind of numbness […]
Medically reviewed by Dr. Lisa Parker, DNP, APRN, NP — Owner & Clinical Director, Parker Neuroscience, Omaha, Nebraska Imagine standing at a locked door, putting a key in, turning it, and nothing happens. Nobody concludes they’re simply bad at opening doors. They realize they need a different key. That same logic applies to depression treatment […]
By Dr. Lisa Parker, DNP, APRN, NP — Owner & Clinical Director, Parker Neuroscience, Omaha, Nebraska Here is the direct answer: ketamine and Spravato® therapy for treatment-resistant depression is outpatient care. That is not a limitation of my practice, and it is not something I work around. It is how this treatment is built to […]
Lisa Parker, DNP, APRN, NP Founder, Parker Neuroscience, LLC | Omaha, Nebraska Most of what gets written about IV ketamine focuses on two questions: does it work, and is it medically safe. Both matter, and the answers are encouraging. A systematic review of 93 clinical trials found that among 3,756 participants who received at least […]
Parker Neuroscience is open and currently credentialing with major insurance carriers and the VA Community Care Network. Coverage varies by service and plan, and self-pay pricing is structured to stay competitive in the Omaha market so advanced treatment is more accessible and equitable for patients.
Spravato is FDA-approved for treatment-resistant depression and may be insurance-eligible depending on plan requirements, documentation, and authorization. Parker Neuroscience can help patients understand REMS enrollment and coverage steps.
IV and IM ketamine are offered as private-pay treatment modalities with transparent pricing discussed during consultation. Pricing is intentionally competitive for the local market to improve access and equity for patients seeking this medicine. Veterans enrolled in the VA Community Care Network may qualify for VA-covered ketamine therapy depending on eligibility and authorization.
Parker Neuroscience currently accepts patients for primary care medication support related to mental health needs. Formal psychiatric medication management services are anticipated to begin in early 2027, and the practice is accepting interest from patients seeking a psychiatric medication provider.
Don't see your plan? Contact us — we will tell you directly what your options are. Advance Care is accepted for eligible self-pay services.
Parker Neuroscience operates on a fully HIPAA-compliant electronic health record platform. All patient records, communications, and billing are protected in accordance with federal privacy standards. Your information is never shared without your explicit written consent.
Parker Neuroscience welcomes referrals from psychiatrists, therapists, primary care providers, and emergency medicine clinicians. We communicate with your team throughout treatment and return your patients to your care with a full clinical summary.
Answer seven brief questions. This is not a diagnosis — it is a clinical starting point to help Dr. Parker understand your situation before your consultation.
Your answers stay on this page only. They are not saved, stored, emailed, or submitted with the contact form.
The first step is a consultation with Dr. Parker to determine whether interventional treatment is right for you. We welcome self-referrals, provider referrals, and general inquiries.
